ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 620 filers reported holding ISHARES TR in Q1 2018. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435 | -0.9% | 3,561 | +3.0% | 0.01% | +16.7% |
| Q2 2023 | $439 | -1.8% | 3,458 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $447 | -3.0% | 3,458 | -1.4% | 0.01% | +16.7% |
| Q4 2022 | $461 | -99.9% | 3,508 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $410,000 | +88.9% | 3,508 | +110.7% | 0.01% | +133.3% |
| Q1 2022 | $217,000 | -98.0% | 1,665 | -97.7% | 0.00% | -98.4% |
| Q4 2021 | $10,895,000 | +2737.2% | 71,386 | +2901.9% | 0.19% | +2628.6% |
| Q3 2021 | $384,000 | -7.2% | 2,378 | -5.9% | 0.01% | -12.5% |
| Q2 2021 | $414,000 | +12.2% | 2,528 | +3.1% | 0.01% | 0.0% |
| Q1 2021 | $369,000 | -35.3% | 2,453 | -34.8% | 0.01% | -38.5% |
| Q4 2020 | $570,000 | +71.7% | 3,765 | +53.5% | 0.01% | +44.4% |
| Q3 2020 | $332,000 | -0.9% | 2,453 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $335,000 | +53.7% | 2,453 | +20.0% | 0.01% | -16.7% |
| Q1 2018 | $218,000 | +847.8% | 2,045 | +2952.2% | 0.01% | +500.0% |
| Q4 2015 | $23,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |